性别影响多发性硬化症治疗决策
Harald Hegen1, Klaus Berek1, Florian Deisenhammer1
1Department of Neurology, Medical University of Innsbruck, Anichstraße 35, 6020, Innsbruck, Austria.
Journal of neurology
|March 5, 2024
概括
性别影响了多发性硬化症治疗决策,女性更有可能停止治疗,通常是为了计划生育. 了解这些差异是为所有患有MS的人提供公平护理的关键.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 多发性硬化症 (MS) 的个体疾病修饰治疗 (DMT) 决策可能在女性和男性患者之间有所不同.
- 现实世界的数据对于理解这些潜在的性别相关差异至关重要.
研究的目的:
- 在现实世界的临床环境中,研究近几十年来DMT策略中基于性别的差异.
- 确定性别是否以及如何影响治疗升级,停止治疗以及多发性硬化症管理中的选择.
主要方法:
- 追溯分析奥地利多发性硬化症治疗注册表 (AMSTR) 数据.
- 包括4224名患有复发性复发性多发性硬化症的患者,分析人口统计数据,疾病活性 (EDSS,ARR,MRI病变) 和DMT病史.
- 用多变量考克斯回归模型来评估基于性别和其他因素的DMT升级和停药的概率.
主要成果:
- 与男性相比,患有多发性硬化症的女性患者由于复发活动而不太可能升级DMT.
- 女性患者更有可能停止中度有效的DMT,特别是在年轻时,并且更有可能停止高效的DMT.
- 计划生育是女性患者停止使用DMT的重要原因,独立于疾病活性指标.
结论:
- 与性别相关的因素在多发性硬化症中显著影响现实世界的DMT决策.
- 对这些性别特异性治疗模式的认识对于减轻MS护理中的潜在不平等至关重要.
- 进一步的研究应探索DMT使用中观察到的性别差异的潜在原因.
相关概念视频
01:41Spermatogenesis
102.4K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.4K
01:21Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K